Scrying Biotech
Long only, biotech, micro-cap, small-cap

Sunshine Heart: An Elementary Question Reveals A Profound Problem

I'm a long-term investor and short-term trader of stocks. I don't buy or sell options, but were I too, I wouldn't hesitate to short Sunshine Heart (SSH) at this time. The reason for this is simple: trial enrollment numbers for 2013 in the pivotal phase 3 Counter-HF trial were abysmal.

I don't want to lose money or have funds tied up in a company whose trial completion date might extend outward like the Emerald City on the road to the Wizard of Oz.

If you want to find out how terrific of a device this is, I want you to read a series of articles by Robert Honeywell right here on Seeking Alpha that address its enormous market...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details